Image For Activity Cover
Expert Approaches to VTE Care for Patients with Obesity
Intended Audience: 

Physicians, NPs, PAs, pharmacists specializing in hematology, primary care, vascular surgery, and radiology involved in the care of patients with VTE

The treatment and management of venous thromboembolism (VTE) in patients with obesity or severe obesity can be a challenge. Join leading experts as they examine the latest efficacy and safety data from subgroup analyses of clinical trials and observational cohort studies in VTE treatment. Challenging case-based scenarios in this patient population will illustrate the application of new evidence into clinical practice.

Don't miss the opportunity to:

  • Review NEW real-world data and hear expert discussion of insights from a VTE booster quiz for providers
  • Hone your skills in clinical decision-making through complex case scenarios
  • Engage in live Q&A with renowned experts in VTE
This webinar is delivered in partnership with The Obesity Society.
Learning Objectives
  • Evaluate implications of current evidence on the safety and efficacy of direct oral anticoagulants (DOACs) from subgroup analyses of clinical trials and observational cohort studies on the management of patients with venous thromboembolism (VTE), including those who are severely obese
  • Differentiate DOACs and conventional anticoagulants for the treatment of VTE in obese and severely obese patients based on clinical trial data regarding their efficacy and safety
  • Apply the latest clinical data to evidence-based, patient-centered treatment decision-making regarding DOACs and conventional anticoagulants to optimize outcomes for obese patients with VTE
  • Align clinical practices with evolving evidence and indications for appropriate integration of DOACs in the treatment and management of obese and severely obese patients
  1. Addressing Challenges in Treating Obese and Severely Obese Patients With Venous Thromboembolism (VTE)
  2. Beyond the Guidelines: Examining Evolving Clinical Evidence in VTE Treatment in Patients With Obesity
  3. Expert Examination of the Safety and Efficacy Data of Direct Oral Anticoagulants (DOACs) and Conventional Anticoagulants
  4. Developing Evidence-Based, Personalized Management Plans for Obese and Severely Obese Patients with VTE

Geoffrey D Barnes, MD, MSc

Geoffrey D Barnes, MD, MSc

Assistant Professor of Internal Medicine
Director, Vascular Medicine Fellowship
Division of Vascular and Cardiovascular Medicine
University of Michigan Frankel Cardiovascular Center
Ann Arbor, MI

Christian T Ruff, MD, MPH

Christian T Ruff, MD, MPH

Director of General Cardiology
Brigham and Women's Hospital
Senior Investigator, TIMI Study Group
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Ali M Moran, DNP, AGACNP

Ali M Moran, DNP, AGACNP

Vascular Medicine Nurse Practitioner
Division of Cardiovascular Medicine
Vanderbilt University Medical Center
Nashville, TN

Joyce M Knestrick, PhD, CRNP, FAANP


Visiting Professor
George Washington University
Family Nurse Practitioner
Wheeling Health Right
Wheeling, WV

Michele B Kaufman, PharmD, BCGP


New York Presbyterian Hospital - Lower Manhattan
New York, NY

Henry A Solomon, MD, FACP, FACC

Peer Reviewer

Cardiologist and Internal Medicine Physician
New York, NY

CE Details & Instructions

Joint Accreditation Statement

IPCE Credit™
In support of improving patient care, PRIME® is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional Teams

Joint AccreditationThis activity was planned by and for the healthcare team, and learners will receive 1.0 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physician Credit Designation Statement


PRIME® designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.


Physician Assistant Accreditation Statement


PRIME® has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioner Accreditation Statement

Nurse Practitioner LogoPRIME Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 060815. This activity is approved for 1.0 contact hour (which includes 0 hour of pharmacology).

Pharmacist Accreditation Statement


This Application-based activity has been approved for 1.0 contact hour (0.1 CEUs) by PRIME® for pharmacists. The Universal Activity Number for this activity is JA0007144-0000-21-199-L01-P . Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity by providing your NABP ID & DOB, which must be submitted within 60 days of completion. Pharmacists with questions can contact NABP customer service ([email protected]).

Nurse Accreditation Statement


PRIME® designates this activity for 1.0 contact hour.

Obtaining CE Credit
  1. Register using the online form
  2. Complete the pre-registration survey
  3. Attend the live program in its entirety
  4. Complete an online evaluation and post-test
  5. Download and/or print a certificate of completion and/or submit CE credits electronically

Instructions to access CME/CE credit options will be provided at the end of the program.

Method of Participation
This live CME/CE activity requires attendance of the participant during the entire program and completion of learner assessment tools. The learner will then receive instructions on how to download and/or print a certificate of completion and/or submit CE credits electronically.
Device Requirements
  • Hardware: an Internet-enabled computer, smartphone, tablet, or mobile device with audio capabilities and Internet connectivity
  • Software: the installation of software such as GoToWebinar may be required
Faculty Disclosures

*PRIME® has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity.

The following individuals have identified relevant financial relationships with commercial interests to disclose:

  • Geoffrey D Barnes, MD, MSc (Speaker)
    Advisory Board or Panel – JanssenPfizer/Bristol Myers Squibb
    Consultant – Acelis Connected HealthJanssenPfizer/Bristol Myers Squibb
  • Christian T Ruff, MD, MPH (Speaker)
    Advisory Board or Panel – AnthosBayerBoehringer IngelheimBristol-Myers SquibbDaiichi SankyoJanssenPfizerPortola
    Consultant – AnthosBayerBoehringer IngelheimBristol-Myers SquibbDaiichi SankyoJanssenPfizerPortola
    Grants / Research Support – AnthosAstraZenecaBoehringer IngelheimDaiichi SankyoNational Institutes of Health

The following individuals have no relevant financial relationships with commercial interests to disclose:

  • Ali M Moran, DNP, AGACNP (Moderator)
  • Henry A Solomon, MD, FACP, FACC (Reviewer)
  • Joyce M Knestrick, PhD, CRNP, FAANP (Planner)
  • Michele B Kaufman, PharmD, BCGP (Planner)

All PRIME® staff participating in planning and content development have no relevant financial relationships with commercial interests to disclose.

Funding Disclosure
This activity is provided by PRIME Education. There is no fee to participate.This activity is supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.
Accessibility Statement
At PRIME, we are committed to ensuring that individuals with disabilities can access all of the content offered by PRIME through our website and other properties. If you are having trouble accessing, please email [email protected] for assistance. Please put "ADA Inquiry" in the subject line of your email.
Cost: FREE
No Credit Offered
             Submit a Support Ticket
             Write Us a Friendly Review